不含麩質 - 本產品不含可檢測出之麩質*

不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份

素食品 - 本產品為素食產品

等滲壓營養補充沖飲 - 易於飲用的營養補充品 / 健康食品，透過等滲壓狀態達致更佳的營養吸收

品質標準 - 良好生產規範(GMP)運作與標準化成份

已檢測：重金屬丶微生物污染物丶過敏原丶效力丶純度及特性

*美國食品藥品監督管理局（FDA）將含有少於20PPM麩質的製成產品列為不含麩質

鈣
奶類含有高濃度的鈣，其他含豐富鈣質的食物包括蔬菜如羽衣甘藍、黃芽白、芥菜、西蘭花、白菜及豆腐。鈣是一種必要的礦物質，具有多方面的生物用途。

骨骼是鈣的儲存庫。除了作為骨頭及牙齒的主要成份外，鈣還支援正常的肌肉收縮和神經健康。

人們每日必需攝取足夠的鈣，以維持最佳的骨質密度、骨骼及牙齒健康。若人體每日吸收的鈣質不足，就會從骨頭裏提取鈣來使用。

鎂
富含鎂的食物包括未經打磨的穀物、果仁及綠色蔬菜。由於綠葉菜的葉綠素含量高，因此是鎂的豐富來源。肉類、澱粉質、奶類產品及經精製和加工的食物的鎂含量低。近期的調查發現，大部份人飲食中的鎂含量不足。

鎂是骨頭內礦物質部份的其中一種成份，能支援成年人正常的鉀及鈣代謝作用。鎂有助維持正常的鉀、磷及鈣水平，並促進肌肉及神經組織的正常功能。

鎂還支援人體發展健康骨骼、牙齒及肌肉的能力。鎂與鈣及維他命D相互合作，有助維持骨骼強壯。

錳
錳是一種大量存在於植物及動物物質內的礦物質。富含錳的食物來源包括全穀物、果仁、有葉菜及茶。含錳濃度最高的是穀物的穀皮部份，但通常穀物在加工時，穀皮都會被去除。
錳支援正常的結締組織和骨骼的形成，並支援鈣的吸收。

維他命C（抗壞血酸）
蘊藏豐富維他命C的食物來源包括所有柑橘屬水果（橙、西柚、檸檬及柑）、士多啤梨、蕃茄、西蘭花、小椰菜、辣椒及哈蜜瓜。維他命C 是一種「脆弱」的維他命，食物經過烹煮或曝露於氧氣中就很容易破壞當中的維他命C。

維他命C支援身體使用其他多種維他命及礦物質的能力，例如硫胺素、核黃素、泛酸、生物素、葉酸、B12、視黃酫、α-生育酚及礦物鈣。維他命C在正常的葉酸、部份氨基酸及荷爾蒙的代謝作用上，擔當輔因子或輔助者的角色。作為一種有效的抗氧化物，維他命C還支援鐵在小腸的吸收，並支援膠原蛋白的正常合成。維他命C 成為了全球最受歡迎的維他命。

壓力、吸煙及部份藥物會阻礙人體吸收、保持及使用維他命C的能力。由於維他命C為水溶性，因此每日都會被排出體外，而因為人們日常進食的食物維他命C含量不足，所以服用補充品會為人體健康帶來好處。

維他命D3（膽鈣化醇）
人類主要透過適量曬太陽取得維他命D。含有維他命D的食物來源包括添加維他命D的奶類、魚肝油及三文魚等含脂肪魚類，而蛋黃及肝臟亦含少量維他命D。

維他命D促進鈣及磷的吸收，並支援幾種參與鈣吸收及儲存過程的蛋白質製造。維他命D與鈣相互合作，促進骨骼強壯、堅固，並支援鈣從成骨細胞輸出至細胞外液以及在腎臟內的傳送。此外，維他命D還促進鈣及磷酸鹽在腎小管及腸道上皮層被再次吸收。

鉀
鉀是儲存於肌肉中的電解質。富含鉀的食物來源包括香蕉、橙、哈蜜瓜、牛油果、未經煮熟的菠菜、椰菜及芹菜。鉀是一種必要的主要礦物質，有助維持人體內的液體平衡，同時參與多種生化及生理過程。鉀支援正常的肌肉活動。

為甚麼要服用鈣？
人人都需要鈣，基本上，沒有人能從日常飲食攝取足夠的鈣。除了有助支援及維持骨質密度外，作為礦物質，鈣還擔當活躍的角色。在支援多種酵素活動及維持適當液體平衡上，鈣亦非常重要。鈣還促進正常的肌肉收縮及骨骼健康。

我並非老年女士，為甚麼要服用鈣補充品？
不論任何年齡，在身體眾多過程中，鈣均扮演著相當重要的角色。雖然年紀大的女性較容易有骨質流失，但年輕女性、懷孕及哺乳的婦女，甚至是男士也應該服用鈣補充品。

年輕女性需要更多的鈣來鞏固骨骼。懷孕及哺乳的婦女需要額外的鈣供新細胞健康成長或餵哺母乳。最後，心血管系統健康不佳的人也被發現所吸收的鈣量很低。

建議開始服用Isotonix鈣高效吸收沖飲的年齡為多少？
我們建議18歲或以上的成年人均可服用Isotonix 鈣高效吸收沖飲。

為甚麼Isotonix 鈣高效吸收沖飲較其他鈣補充品優越？ 
Isotonix 鈣高效吸收沖飲較為優越是因為其Isotonix傳送系統。現在，等壓過程的秘密將逐漸解開。當一種等壓物質進入人體時，會迅即被吸收進入血液。透過等壓溶液，物質的營養流失較少，令營養吸收更有效。等壓溶液是天然的營養輸送系統。

為甚麼與水混合後杯裏會出現沙狀的沉澱物？
人人飲用的水都不同；有些自來水含有較高濃度的礦物質，而水的酸鹼度也因應地理位置及自來水的質素而有所不同，因而導致一種溶液的飽和點不同。為確保我們的溶液不受酸鹼度或礦物質濃度影響而達到飽和點，我們將配方的份量提升至最高，因此每一份Isotonix 鈣高效吸收沖飲都包含正確份量的鈣。杯內的沉積物是因為溶液超過了飽和點而造成，這情況在鹼性高或礦物質含量高的自來水中很常見。

使用Isotonix鈣高效吸收沖飲安全嗎？
Isotonix鈣高效吸收沖飲安全及不含有害物質。本產品在美國製造，並於經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

• Abbott L, Nadler J, Rude RK. Magnesium deficiency in alcoholism: possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcohol Clin Exp Res. 1994; 18:1076-1082.
• Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
• Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode.
  
• Alcohol Clin Exp Res. 1994; 18:1057-1068.
• Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
• Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
• Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
• Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
• Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441- 2444.
• Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol   1999;149:151-160.
• Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
• Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968.
• Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
• Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a   canine model. Circulation. 1995; 92:2617-2621.
• Christin Marandino, Vegetarian Times, August 1998 Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504.
• Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J      Med. 1997; 337:670-676.
• de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998;      21:682-686.
• Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
• Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
• Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
• Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119.
• Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320.
• Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-   990.
• Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL.
• Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
• Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S.
• Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24.
• ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet.1995; 345:669-685.
• Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159.
• Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
• Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
• Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy.Lancet. 1995; 346:270-274.
• Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
• Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384.
• Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
• Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
• Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
• Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69.
• Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
• Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation.Lancet. 1999; 353:296-297.
• Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999;159:2119-2120.
• Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269.
• Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263.
• Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in      postmenopausal women. N Engl J Med. 1993; 328:460-464.
• Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423.
• Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251.
• Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145.
• Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26.
• Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in
  
• Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192.
• Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
• Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825.
• Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
• Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150.
• Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064.
• Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142.
• Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
• Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148.
• Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
• Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
• Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
• Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819.
• Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.